{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:09Z","timestamp":1762867089976},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,30]]},"DOI":"10.18632\/oncotarget.16751","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T21:59:22Z","timestamp":1490997562000},"page":"36319-36330","source":"Crossref","is-referenced-by-count":13,"title":["Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing"],"prefix":"10.18632","volume":"8","author":[{"given":"Mengdan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Sui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China"},{"name":"Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiju","family":"Ji","sequence":"additional","affiliation":[{"name":"Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China"},{"name":"Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China"},{"name":"Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Sharma","year":"2003","journal-title":"Lancet Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"967472","DOI":"10.1155\/2015\/967472","article-title":"Gallbladder Cancer in the 21st Century","volume":"2015","author":"Kanthan","year":"2015","journal-title":"J Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Gazdar","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.suronc.2012.08.002","article-title":"Gallbladder cancer: past, present and an uncertain future","volume":"21","author":"Somasundar","year":"2012","journal-title":"Surg Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejso.2007.07.206","article-title":"Gallbladder carcinoma","volume":"34","author":"Jarnagin","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/CLEP.S37357","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Shaffer","year":"2014","journal-title":"Clin Epidemiol"},{"key":"7","first-page":"461","article-title":"High frequency of p53 gene mutation in adenocarcinomas of the gallbladder","volume":"5","author":"Tahara","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0959-8049(97)00080-4","article-title":"TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns","volume":"33","author":"Kajiyama","year":"1997","journal-title":"Eur J Cancer"},{"key":"9","first-page":"297","article-title":"Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile","volume":"7","author":"Hatakeyama","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat Genet"},{"key":"11","first-page":"2511","article-title":"Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile","volume":"55","author":"Gazdar","year":"1995","journal-title":"Cancer Res"},{"key":"12","first-page":"49","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Perucho","year":"1988","journal-title":"Cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M","article-title":"K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct","volume":"77","author":"Kajiyama","year":"1996","journal-title":"Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1752::AID-CNCR51>3.0.CO;2-V","article-title":"K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction","volume":"77","author":"Hirono","year":"1996","journal-title":"Cancer"},{"key":"15","first-page":"1457","article-title":"Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts","volume":"44","author":"Miyoshi","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1572-0241.1999.01155.x","article-title":"Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct","volume":"94","author":"Kajiyama","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Herrera","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"19","first-page":"614","article-title":"Targeting the Raf\/MEK\/ERK pathway with small-molecule inhibitors","volume":"9","author":"Steelman","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc4000","article-title":"MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road","volume":"15","author":"Cook","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2005.06.009","article-title":"Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin","volume":"19","author":"Li","year":"2005","journal-title":"Mol Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Bottomley","year":"2002","journal-title":"Nature"},{"key":"23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrc1836","article-title":"Pathogenetic mechanisms in thyroid follicular-cell neoplasia","volume":"6","author":"Asa","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"24","first-page":"179","article-title":"Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability","volume":"445","author":"Patsouris","year":"2004","journal-title":"Virchows Arch"},{"key":"25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ceb.2007.02.010","article-title":"Receptor tyrosine kinases: mechanisms of activation and signaling","volume":"19","author":"Miller","year":"2007","journal-title":"Curr Opin Cell Biol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Schlessinger","year":"2010","journal-title":"Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers7030860","article-title":"Targeting RTK Signaling Pathways in Cancer","volume":"7","author":"Regad","year":"2015","journal-title":"Cancers (Basel)"},{"key":"28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0344-0338(11)80511-X","article-title":"An immunohistochemical and molecular biological study of c-erbB-2 amplification and prognostic relevance in gallbladder cancer","volume":"189","author":"Okudaira","year":"1993","journal-title":"Pathol Res Pract"},{"key":"29","first-page":"1055","article-title":"Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract","volume":"15","author":"Su","year":"1995","journal-title":"Anticancer Res"},{"key":"30","first-page":"1127","article-title":"Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas","volume":"8","author":"Hong","year":"2001","journal-title":"Oncol Rep"},{"key":"31","first-page":"6971","article-title":"Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma","volume":"61","author":"DiGiovanni","year":"2001","journal-title":"Cancer Res"},{"key":"32","first-page":"4","article-title":"MAP Kinase Pathways","author":"Morrison","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Kolch","year":"2007","journal-title":"Oncogene"},{"key":"34","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2010.33.9473","article-title":"Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers","volume":"29","author":"Marsh","year":"2011","journal-title":"J Clin Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","article-title":"GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustainedpathway inhibition","volume":"17","author":"Sutton","year":"2011","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Durbin","year":"2010","journal-title":"Bioinformatics"},{"key":"37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"Kernytsky","year":"2011","journal-title":"Nat Genet"},{"key":"38","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","article-title":"VarScan: variant detection in massively parallel sequencing of individual and pooled samples","volume":"25","author":"Ding","year":"2009","journal-title":"Bioinformatics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T15:11:39Z","timestamp":1596726699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":38,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017,5,30]]}},"alternative-id":["16751","28422736"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16751","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}